TABLE 3.

Plasma and anthropomorphic cardiovascular risk markers before and after consuming the ketone monoester

	Baseline	After 28 days
Triglycerides (mM)	1.18 ± 0.57	1.10 ± 0.43
Cholesterol (mM)	5.35 ± 1.3	5.84 ± 1.08
HDL (mM)	1.84 ± 0.54	1.84 ± 0.57
ApoB (mM)	0.9 ± 0.3	0.9 ± 0.3
C‐reactive protein (mg/L)	2.1 ± 0.9	1.9 ± 0.9
Total weight (kg)	96.7 ± 15.7	95.4 ± 15.6
Total body fat %	33.2 ± 6.6	33.0 ± 6.6
Visceral fat %	12.4 ± 2.7	12.3 ± 2.8
ALT (U/L)	41 ± 15	38 ± 17
AST (U/L)	40 ± 14	38 ± 15
NEFA (mM)	1.03 ± 0.19	0.99 ± 0.20
HOMA–IR a	1.66 ± 0.37	1.48 ± 0.45
10‐year fatal CHD risk a (%)	7.7 ± 3.3	7.3 ± 3.9

Data are means ± standard deviations. All variables were compared against a baseline using a two‐tailed paired Student's t‐test. p was >.05 for all comparisons.

^a HOMA and 10‐year fatal coronary heart disease risk were calculated using an open access diabetes‐specific calculator available at https://www.dtu.ox.ac.uk/riskengine/download.php